The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Busulfan, melphalan, and carfilzomib (BuMelCar) conditioning for autologous stem cell transplant (ASCT) in multiple myeloma: Phase I/II data.
 
Joseph Allan Norton
No Relationships to Disclose
 
Patrick Hagen
Speakers' Bureau - Bristol-Myers Squibb; Sanofi
 
Stephanie Tsai
Speakers' Bureau - Bristol-Myers Squibb; Jazz Pharmaceuticals
 
Scott E. Smith
No Relationships to Disclose
 
Mary Lee
No Relationships to Disclose
 
Loredana Campo
No Relationships to Disclose
 
David Oldenburg
No Relationships to Disclose
 
Patrick J. Stiff
Consulting or Advisory Role - Crispr Therapeutics
Research Funding - Actinium Pharmaceuticals; Amgen (Inst); Atara Biotherapeutics; Gamida Cell; Incyte; Kite, a Gilead Company; MacroGenics; Seagen; Takeda; TG Therapeutics